MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

25 Nov 2020 Evaluate

Alembic Pharmaceuticals has informed that the Company's joint venture, Aleor Dermaceuticals, has received US Food and Drug Administration (USFDA) Tentative Approval for Testosterone Gel, 1.62% (20.25 mg/ 1.25 gm actuation). The company has enclosed a press on 25th November 2020 regarding the announcement.

The above information is a part of company’s filings submitted to BSE.





Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..